Clinical Trial Update: Study of the Impact of DPD Activity on the Efficacy of Capecitabine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating how dihydropyrimidine dehydrogenase (DPD) activity influences the efficacy of capecitabine in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Breast Neoplasm Malignant Female | Phase 2 | Status: ACTIVE_NOT_RECRUITING